THOR Photomedicine

What THOR Photomedicine does

THOR Photomedicine is a privately held UK-based medical device company headquartered in Chesham and founded in 2007. The company manufactures and distributes Low-Level Laser Therapy (LLLT) devices — also referred to as photobiomodulation systems — to clinical and hospital customers worldwide, reporting more than 3,000 active customers across 70 countries and self-positioning as the only dedicated LLLT company in the market. Its end customers are pioneering clinics and hospitals using light-based therapy for pain management, wound healing, inflammation reduction, and related therapeutic indications; specific product SKUs, technical architectures, wavelengths, and regulatory clearances are not detailed in the available sources.

The firm is led by founder and CEO James Carroll, with Randall Bergstedt serving as Director of Marketing and Sales. Headcount sits in the 11–50 employee range, consistent with a focused specialist manufacturer operating a direct-plus-distributor commercial model rather than a mass-market medical device business. The company operates within the broader global photomedicine market, which the available market data sizes at USD 5.53 billion in 2026, projected to reach USD 11.85 billion by 2033 (11.5% CAGR), with North America holding an estimated 33.5% share and Asia Pacific forecast as the fastest-growing region at a CAGR exceeding 20.3%.

Revenue mechanics, pricing structure, ownership, funding history, channel mix, certifications, and patent portfolio are not present in the input data, and the company's primary web property returned only a verification/loader page with no substantive content. As such, the business model's specifics — whether revenue is predominantly hardware sales, recurring consumables, service contracts, or a mix — cannot be evidenced and remains a data gap for diligence.

Name

THOR Photomedicine

Website

https://thorlaser.com

Company type

Private

Founded year

2007

Operating status

Operating

Headcount range

11–50 employees

Short description

THOR Photomedicine is a UK-based medical device company founded in 2007 that manufactures Low-Level Laser Therapy (LLLT) devices for clinics and hospitals, serving more than 3,000 customers across 70 countries as a dedicated LLLT specialist.

Ownership category

akta.pro rank

Headquarters

HQ city

Chesham

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Core offering

THOR Photomedicine designs, manufactures, and sells Low-Level Laser/Light Therapy (LLLT) / photobiomodulation devices for clinical use. Its products are used by pioneering clinics and hospitals worldwide for therapeutic light-based treatments, with more than 3,000 customers across 70 countries. The company is described as the only dedicated LLLT company in the industry.

Differentiator

Problem solved

Functional benefit

Products and services

• Low-Level Laser/Light Therapy (LLLT) Devices Clinical-grade photobiomodulation / low-level laser therapy devices sold to clinics, hospitals, and specialist medical practices in 70 countries. Used by healthcare providers for non-invasive, drug-free therapeutic light-based treatments.

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves2 records

Expansion highlights3 records

Direct peers

• Erchonia Corporation: US-based pioneer in low-level laser therapy and photobiomodulation devices for pain, wound healing, and rehabilitation. Directly comparable to THOR as one of the most established pure-play LLLT manufacturers targeting clinics and hospitals with similar clinical claims and customer base.
• Biolux Research: Developer of photobiomodulation (PBM) devices marketed under the OrthoPulse brand and for clinical use. A direct LLLT peer targeting orthodontics and clinical practices, overlapping with THOR in light-based therapeutic device technology.
• Multi Radiance Medical: Manufacturer of FDA-cleared low-level laser therapy and photobiomodulation devices for clinical and veterinary use. A direct THOR competitor offering similar super-pulsed laser platforms to physiotherapy, pain management, and rehabilitation clinics.
• LiteCure: Manufacturer of low-level laser therapy devices serving human and veterinary clinical markets. Competes head-to-head with THOR in selling photobiomodulation systems to physiotherapy, chiropractic, and sports medicine practices globally.

Emerging players

• Aspen Laser Systems: US-based LLLT/PBM device manufacturer selling into pain management, physical therapy, and veterinary clinics. Emerging competitor with a more focused commercial motion in a narrower set of indications than THOR.
• Capillus: US-based manufacturer of low-level laser devices primarily for hair growth applications. Adjacent LLLT specialist using similar photonic technology but focused on a specific consumer/clinical use case rather than THOR's broader therapy indications.

Regional players

• Mectronic Medicale: Italian manufacturer of LLLT and high-intensity laser therapy devices for physiotherapy, rehabilitation, and sports medicine. Comparable product category to THOR but with stronger European regional penetration and a broader laser power range.
• Irradia International: Swedish developer and manufacturer of therapeutic low-level laser devices used by physiotherapists and chiropractors across Europe. Regional LLLT peer with overlapping clinical customer base in physiotherapy and rehabilitation.

Broad incumbents

• Chattanooga Group (DJO Global / Enovis): Broad rehabilitation and physical therapy equipment incumbent whose laser therapy product lines overlap with THOR's clinical use cases. Serves the same physiotherapy and sports medicine channels but as part of a much larger orthopaedic and rehab portfolio.
• BTL Industries: Global medical device company with a growing presence in laser-based and electromagnetic therapy systems across aesthetics, physiotherapy, and orthopaedics. Relevant as a well-funded incumbent expanding into energy-based treatment modalities adjacent to THOR.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/thorlaser
• Facebookfacebook.com/thorlaser
• LinkedInlinkedin.com/company/thor-photomedicine-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about THOR Photomedicine